vimarsana.com
Home
Live Updates
LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test : vimarsana.com
LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test
LumiraDx submits a traditional 510 Dual Submission for LumiraDx SARS-CoV-2 Ag Ultra with CLIA Waiver for the commercial distribution at point of care of the LumiraDx Platform, including the LumiraDx...
Related Keywords
London ,
City Of ,
United Kingdom ,
United States ,
Carol Adiletto Francis ,
Drug Administration ,
Lumiradx Limited Nasdaq ,
Exchange Commission ,
Dual Submission ,
Lumiradx Platform ,
Lumiradx Instrument ,
Quality Control Swab ,
Emergency Use Authorizations ,
Ultra Test ,
Clinical Regulatory ,
Securities Litigation Reform Act ,
Annual Report ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.